Tan, P.C. and Khine, P.P. and Vallikkannu, N. and Omar, S.Z. (2010) Promethazine compared with metoclopramide for hyperemesis gravidarum a randomized controlled trial. Obstetrics and Gynecology, 115 (5). pp. 975-981. ISSN 0029-7844, DOI https://doi.org/10.1097/AOG.0b013e3181d99290.
Full text not available from this repository.Abstract
OBJECTIVE: To compare the effects of promethazine with those of metoclopramide for hyperemesis gravidarum. METHODS: Women at their first hospitalization for hyperemesis gravidarum were approached when intravenous antiemetic therapy was needed. They were randomly assigned to receive 25 mg promethazine or 10 mg metoclopramide every 8 hours for 24 hours in a double-blind study. Primary outcomes were vomiting episodes by diary and well-being visual numerical rating scale score (10-point scale) in the 24-hour main study period. Participants also filled out an adverse-effects questionnaire at 24 hours and a nausea visual numerical rating scale score at recruitment and at 8, 16, and 24 hours. RESULTS: A total of 73 and 76 women, randomized to metoclopramide and promethazine, respectively, were analyzed. Median vomiting episodes were one (range 0-26) compared with two (range 0-26) (P=.81), and well-being visual numerical rating scale scores were 8 (range 1-10) compared with 7 (range 2-10) (P=.24) for metoclopramide and promethazine, respectively. Repeat-measures analysis of variance of the nausea visual numerical rating scale scores showed no significant difference between study drugs (F score=0.842, P=.47). Reported drowsiness (58.6 compared with 83.6, P =.001, number needed to treat to benefit NNTb 5), dizziness (34.3% compared with 71.2%, P<.001, NNTb 3), dystonia (5.7% compared with 19.2%, P=.02, NNTb 8), and therapy curtailment owing to adverse events (0 of 73 0% compared with 7 of 76 9.2%, P=.014) were encountered less frequently with metoclopramide. CONCLUSION: Promethazine and metoclopramide have similar therapeutic effects in patients who are hospitalized for hyperemesis gravidarum. The adverse effects profile was better with metoclopramide.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Uncontrolled Keywords: | Placebo-controlled trial; clinical indicators; severity; efficacy |
| Subjects: | R Medicine R Medicine > RG Gynecology and obstetrics |
| Divisions: | Faculty of Medicine |
| Depositing User: | Ms Haslinda Lahuddin |
| Date Deposited: | 16 Jul 2014 00:06 |
| Last Modified: | 16 Jul 2014 00:06 |
| URI: | http://eprints.um.edu.my/id/eprint/10848 |
Actions (login required)
 |
View Item |
